Translating Collagen Repair Mechanisms to Skin Rejuvenation: Topical, Injectable, and Oral Strategies

Collagen Skin

Abstract

Background: Chronic photoexposure and chronological aging alter the dermal microenvironment through an uncoupling of matrix homeostasis, driven by a downregulation of procollagen synthesis and a reciprocal upregulation of matrix-degrading metalloproteinases (MMPs). This creates a low-grade, chronic inflammatory state—termed "inflammaging" that leads to structural fibroblast collapse. Modern collagen therapies have shifted from passive aesthetic space-fillers to active agents of reparative medicine designed to disrupt this degradative cascade.

Objective: This narrative review synthesizes translational evidence regarding the molecular mechanisms and clinical efficacy of topical, injectable, and oral collagen strategies for cutaneous rejuvenation.

Methods: High-level clinical evidence, including systematic reviews, meta-analyses, and randomized controlled trials (RCTs), was evaluated to analyze cellular signaling pathways and structural outcomes.

Results: Topical formulations utilizing low-molecular-weight peptides (<3–5 kDa) bypass the stratum corneum barrier to trigger keratinocyte paracrine signaling and dermal hyaluronic acid upregulation, achieving a standardized mean difference (SMD) of 0.62 for deep hydration. In injectable applications, the transition to recombinant human collagen (rhCollagen) eliminates xenogeneic risk and immunogenicity; when cross-linked or formulated as monophasic hybrid hydrogels with hyaluronic acid, tissue longevity is extended to 9–12 months while inducing robust host neo-collagenesis. Systemically, oral administration of bioactive di- and tri-peptides (Pro-Hyp, Hyp-Gly) via the intestinal PepT1 transporter achieves cutaneous tissue accumulation for up to 96 hours, demonstrating Level-1 efficacy (SMD 0.85 for hydration; SMD 0.70 for elasticity).

Conclusion: Evidence-based collagen modalities successfully modulate the cutaneous microenvironment. Future clinical paradigms are directing these biomaterials toward personalized nutrigenomics and smart, MMP-responsive matrix hydrogels.